3371 - 3380 of 8571 Results
Title
Year
-
OPENTitle: Testing the Protein Propagation Hypothesis of Parkinson DiseaseJournal Name: Journal of Experimental NeurosciencePublisher: SAGE PublicationsVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1179069518786715Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1179069518786715Citation Count: 27
- CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies2018OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6429430Citation Count: 41
-
OPENTitle: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic StimulationJournal Name: ResearchPublisher: American Association for the Advancement of Science (AAAS)Vol: 2019Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.34133/2019/7109535Best OA location URL: http://downloads.spj.sciencemag.org/research/2019/7109535.pdfCitation Count: 7
-
OPENTitle: The In Situ Structure of Parkinson’s Disease-Linked LRRK2Journal Name: CellPublisher: Elsevier BVVol: 182Issue #: 6Start Page: 1508End Page: 1518.e16Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.cell.2020.08.004Best OA location URL: https://doi.org/10.1016/j.cell.2020.08.004Citation Count: 192
- Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer’s disease spectrum2025RESTRICTEDTitle: Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer’s disease spectrumJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 150Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-025-02914-2Citation Count: 0
- Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning2022OPENTitle: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 12Start Page: 2376End Page: 2385Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29205Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29205Citation Count: 10
- Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model2020OPENTitle: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent modelJournal Name: BMC Research NotesPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13104-020-04994-7Best OA location URL: https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-020-04994-7Citation Count: 16
- Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study2021OPENTitle: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.11.027Citation Count: 7
- The highly selective mGlu2 receptor positive allosteric modulator LY‐487,379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: The highly selective mGlu2 receptor positive allosteric modulator LY‐487,379 alleviates l‐DOPA‐induced dyskinesia in the 6‐OHDA‐lesioned rat model of Parkinson's diseaseJournal Name: European Journal of NeurosciencePublisher: WileyVol: 51Issue #: 12Start Page: 2412End Page: 2422Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14679Citation Count: 16
-
OPENTitle: Sex and Gender Influence Urinary Symptoms and Management in Multiple System AtrophyJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 16Issue #: 2Start Page: 196End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.23016Best OA location URL: https://www.e-jmd.org/upload/jmd-23016.pdfCitation Count: 6